Intellectual Disability
Psychiatry · Childhood · lean revision notes
Intellectual Disability
Intellectual Disability (ID) is a neurodevelopmental disorder of onset before 18 years, characterised by significant deficits in intellectual functioning (reasoning, problem-solving, abstract thinking) AND adaptive functioning (conceptual, social, practical domains). It is the single most common developmental disability and a perennial NEET PG favourite for its crisp IQ cut-offs, prevalence figures, and "most common cause" one-liners.
High-yield: The modern definition (DSM-5 / ICD-11) requires deficits in BOTH intellectual AND adaptive functioning, with onset during the developmental period. IQ alone no longer defines severity — adaptive functioning does in DSM-5.
Definition & terminology
- Old term: Mental Retardation (MR) — used in DSM-IV and ICD-10. Now obsolete and stigmatising.
- DSM-5 term: Intellectual Disability (Intellectual Developmental Disorder).
- ICD-11 term: Disorders of Intellectual Development.
- Core triad:
- Deficits in intellectual functions (confirmed by clinical assessment + standardised IQ testing).
- Deficits in adaptive functioning leading to failure to meet developmental/sociocultural standards for independence and social responsibility.
- Onset during the developmental period (before 18 years; if onset after maturity it is dementia, not ID).
High-yield: If intellectual decline begins AFTER full brain maturation (e.g., after 18), the diagnosis is dementia, NOT intellectual disability. Onset timing is the discriminator.
Classification & IQ cut-offs
IQ is calculated as (Mental Age / Chronological Age) × 100. The population mean IQ is 100 with a standard deviation (SD) of 15. Intellectual disability begins below IQ 70 (i.e., 2 SD below the mean).
| Severity | IQ range | Mental age (approx, adult) | DSM-IV / ICD-10 proportion |
|---|---|---|---|
| Mild | 50–69 | 9 to <12 years | ~85% |
| Moderate | 35–49 | 6 to <9 years | ~10% |
| Severe | 20–34 | 3 to <6 years | ~3–4% |
| Profound | Below 20 | <3 years | ~1–2% |
High-yield: Memorise the cut-offs cold — Mild 50–69, Moderate 35–49, Severe 20–34, Profound <20. "Borderline intellectual functioning" = IQ 70–84 (NOT classified as ID).
Mnemonic for IQ bands (descending by 15): "69 → 49 → 34 → 20" — note the gaps are roughly 15 (one SD) each. Or remember the upper limits: 70, 50, 35, 20.
High-yield: DSM-5 deliberately de-emphasises IQ scores and grades severity by ADAPTIVE FUNCTIONING (conceptual, social, practical), because adaptive deficits determine the level of support required. ICD-10/clinical practice and most NEET PG MCQs still test the IQ ranges above — know both.
Adaptive functioning domains (DSM-5)
- Conceptual — language, reading, writing, maths, reasoning, memory.
- Social — empathy, interpersonal communication, friendships, social judgement.
- Practical — self-care, job responsibility, money management, recreation, organising tasks.
Epidemiology
- Prevalence: approximately 1–3% of the general population (commonly quoted as ~1%).
- Sex: More common in males (M:F roughly 1.5:1), partly due to X-linked causes (e.g., Fragile X).
- Mild ID forms the overwhelming majority (~85%) and is often idiopathic / sociocultural-familial (polygenic + psychosocial deprivation), frequently with no identifiable organic cause.
- Severe/profound ID is more likely to have an identifiable biological cause.
High-yield: Prevalence of ID ≈ 1–3%. Most cases are MILD. Most identifiable single causes are biological, but a large share of mild ID has no identifiable cause (idiopathic).
Aetiology & pathophysiology
Causes are grouped by timing (prenatal, perinatal, postnatal). Prenatal causes dominate.
| Period | Examples |
|---|---|
| Prenatal | Chromosomal (Down, Fragile X, Prader-Willi, cri-du-chat); single-gene metabolic (PKU, galactosaemia, Tay-Sachs); neural tube defects; congenital hypothyroidism; TORCH infections; Fetal Alcohol Syndrome (FAS); teratogens (valproate, phenytoin, thalidomide) |
| Perinatal | Birth asphyxia / hypoxic-ischaemic encephalopathy, prematurity/low birth weight, kernicterus (severe neonatal jaundice), birth trauma, neonatal hypoglycaemia, neonatal sepsis/meningitis |
| Postnatal | CNS infections (meningitis, encephalitis), head trauma, lead/mercury poisoning, severe malnutrition, hypothyroidism, psychosocial deprivation, hypoxia (near-drowning), iodine deficiency |
High-yield: Down syndrome (Trisomy 21) is the single MOST COMMON identifiable / genetic cause of intellectual disability. Fragile X syndrome is the most common INHERITED (heritable) cause and the most common single-gene cause. Fetal Alcohol Syndrome is the most common PREVENTABLE / environmental cause.
High-yield: Iodine deficiency is the most common preventable cause of ID worldwide (endemic cretinism). Phenylketonuria (PKU) is the classic preventable metabolic cause — preventable by newborn screening + dietary phenylalanine restriction.
Key syndromic associations (very high-yield for MCQs)
| Condition | Genetics / mechanism | Clinical clue |
|---|---|---|
| Down syndrome | Trisomy 21 (95% nondisjunction; risk ↑ with maternal age) | Flat facies, epicanthic folds, single palmar (simian) crease, hypotonia, AV septal defect, duodenal atresia, ↑ Alzheimer & ALL risk |
| Fragile X | CGG triplet repeat expansion, FMR1 gene, X-linked | Long face, large ears, macro-orchidism (post-puberty), autism features; commonest inherited ID |
| Prader-Willi | Deletion 15q (paternal) | Hyperphagia, obesity, hypotonia, hypogonadism |
| Angelman | Deletion 15q (maternal) | "Happy puppet", ataxia, inappropriate laughter, seizures |
| Cri-du-chat | 5p deletion | Cat-like cry, microcephaly |
| PKU | Phenylalanine hydroxylase deficiency (AR) | Musty/mousy odour, fair skin, eczema, seizures; Guthrie test |
| Fetal Alcohol Syndrome | Prenatal alcohol | Smooth philtrum, thin upper lip, short palpebral fissures, microcephaly |
| Rett syndrome | MECP2 gene, X-linked (girls) | Normal then regression, hand-wringing stereotypy, deceleration of head growth |
| Tuberous sclerosis | TSC1/TSC2, AD | Ash-leaf macules, adenoma sebaceum, seizures |
| Lesch-Nyhan | HGPRT deficiency, X-linked | Self-mutilation, hyperuricaemia, choreoathetosis |
High-yield: Self-mutilation/self-biting + hyperuricaemia → Lesch-Nyhan. Hand-wringing stereotypies in a girl with regression → Rett. Macro-orchidism + long face → Fragile X.
Clinical features by severity
A stepwise expectation of functional ceiling:
Profound → Severe → Moderate → Mild corresponds to increasing independence.
- Mild (educable): Reach roughly 6th-grade academic level by late teens; can achieve social and vocational skills for minimal self-support; may live independently with support; often not identified until school age when academic demands rise.
- Moderate (trainable): Reach ~2nd-grade academic level; benefit from vocational training; need supervision; can perform semi-skilled work in sheltered settings; manage self-care with prompting.
- Severe: Minimal speech; can be trained in elementary self-care/habits; need close supervision; communicate at a basic level.
- Profound: Highly dependent; need constant care/nursing; minimal sensorimotor functioning; high rate of associated physical disability and neurological deficits.
High-yield: Old descriptive labels — Mild = "Educable", Moderate = "Trainable", Severe/Profound = "Custodial / dependent". Mild ID often presents late (at school entry) precisely because adaptive deficits are subtle until academic demands increase.
Associated comorbidities
- Psychiatric disorders are 3–4× more common than in the general population (ADHD, autism spectrum disorder, anxiety, depression, stereotyped/self-injurious behaviour, impulse-control problems).
- Epilepsy prevalence rises steeply with severity.
- Sensory impairments (vision, hearing) and motor disability are common in severe/profound.
High-yield: "Diagnostic overshadowing" — the tendency to attribute new behavioural/psychiatric symptoms wholly to the ID itself, thereby missing a treatable comorbid psychiatric or medical illness. A classic exam concept.
Diagnosis & investigation of choice
Diagnosis is clinical, combining history (developmental delay, family/perinatal history), physical/neurological exam, and standardised testing.
Diagnostic flow: History + developmental milestones → standardised IQ test (intellectual deficit) → standardised adaptive behaviour scale → confirm onset in developmental period → aetiological work-up.
Psychometric tests (know these for MCQs)
| Test | Purpose / age |
|---|---|
| Stanford-Binet Intelligence Scale | Classic individual IQ test; usable from age 2 to adult |
| Wechsler Intelligence Scale for Children (WISC) | IQ, ages ~6–16 (verbal + performance) |
| Wechsler Adult Intelligence Scale (WAIS) | IQ in adults |
| Wechsler Preschool & Primary Scale (WPPSI) | Young children |
| Vineland Adaptive Behaviour Scale (VABS) | Investigation of choice for adaptive functioning |
| AAIDD Diagnostic Adaptive Behaviour Scale | Adaptive functioning |
| Gesell, Bayley, Denver (DDST) | Developmental screening in infants/young children |
| Seguin Form Board, Bhatia's Battery | Performance/non-verbal tests used in India (Bhatia for low-literacy populations) |
High-yield: IQ test of choice = Stanford-Binet / Wechsler scales. Adaptive functioning assessment of choice = Vineland Adaptive Behaviour Scale (VABS). In India, Bhatia's Battery of Performance Tests is widely used; Seguin Form Board is a quick non-verbal screen.
Aetiological work-up (when cause unknown)
- Karyotyping / chromosomal microarray (CMA) — CMA is now first-line genetic test for unexplained ID (higher yield than karyotype).
- Fragile X DNA testing (CGG repeat) — especially in males with ID + autistic features.
- Thyroid function (congenital hypothyroidism).
- Metabolic screen (tandem mass spectrometry; urine for organic acids; PKU/Guthrie test).
- Neuroimaging (MRI brain) if neurological signs, microcephaly, or seizures.
- EEG if seizures.
- TORCH, lead levels, hearing & vision screening as indicated.
High-yield: First-line genetic test for unexplained global developmental delay / ID = chromosomal microarray (CMA), plus Fragile X testing.
Management
There is no curative drug for the intellectual disability itself; management is multidisciplinary, rehabilitation-based, and aimed at maximising adaptive function and treating comorbidities.
Management pillars: Prevention → early identification → individualised education (IEP) → behavioural & skills training → treat comorbidities → family support & legal/social provisions.
Prevention (most important public-health angle):
- Primary: genetic counselling, rubella immunisation, iodisation of salt, avoiding alcohol/teratogens in pregnancy, good antenatal/perinatal care, folate supplementation.
- Secondary: newborn screening (PKU, congenital hypothyroidism), prenatal diagnosis (amniocentesis, NIPT, USG).
- Tertiary: early intervention to limit disability.
Education & training: Special education, Individualised Education Programme (IEP), vocational rehabilitation, sheltered workshops.
Behaviour therapy: Applied behaviour analysis (ABA), social-skills training, management of self-injurious/aggressive behaviour.
Pharmacotherapy (symptomatic only — treats comorbidities, NOT the ID):
- Aggression/self-injury/irritability (esp. with autism): risperidone, aripiprazole (atypical antipsychotics).
- Comorbid ADHD: methylphenidate.
- Comorbid depression/anxiety: SSRIs.
- Seizures: appropriate antiepileptics.
Disease-specific treatment where available: PKU → phenylalanine-restricted diet; congenital hypothyroidism → levothyroxine; galactosaemia → galactose-free diet.
High-yield: For aggression / self-injurious behaviour in ID (and autism), the most-tested drug is risperidone (FDA-approved for irritability in autism). For the ID itself there is no specific drug — management is rehabilitative.
High-yield: The single most effective public-health intervention to reduce ID worldwide is universal salt iodisation (prevents endemic cretinism). PKU and congenital hypothyroidism are preventable causes if screened early.
Indian legal/social context
- Rights of Persons with Disabilities (RPwD) Act, 2016 recognises intellectual disability and specifies benefit eligibility (≥40% disability for certificate).
- National Trust Act, 1999 covers autism, cerebral palsy, ID, and multiple disabilities.
Complications
- Behavioural and psychiatric comorbidity (self-injury, aggression, ASD, ADHD, mood/anxiety disorders).
- Epilepsy (frequency rises with severity).
- Increased vulnerability to physical, sexual, and emotional abuse / exploitation.
- Social isolation, dependence, caregiver burden.
- Associated medical problems (congenital heart disease, sensory deficits) especially in syndromic ID.
Key differentials
| Condition | How to distinguish from ID |
|---|---|
| Specific Learning Disorder (dyslexia, dyscalculia) | IQ is NORMAL; deficit is circumscribed to a specific academic skill, not global |
| Autism Spectrum Disorder | Core deficit is social communication + restricted/repetitive behaviour; IQ may be normal, low, or high; often coexists with ID |
| Communication / language disorder | Isolated language deficit with otherwise normal cognition |
| Global Developmental Delay (GDD) | Term used for children under 5 years in whom IQ testing is unreliable; ID diagnosed once testable |
| Dementia | Decline AFTER a period of normal development (acquired loss), onset typically in adulthood |
| Borderline intellectual functioning | IQ 70–84; below average but not ID |
| Sensory deprivation (deaf/blind), severe psychosocial neglect | Reversible "pseudo-retardation"; improves with stimulation/correction |
High-yield: Global Developmental Delay is the preferred term under 5 years (when standardised IQ is unreliable); Intellectual Disability is diagnosed only once reliable testing is possible. Normal IQ + isolated academic deficit = Specific Learning Disorder, NOT ID.
Recently asked / exam angle
- IQ ranges matched to severity grade (the most repeated single-line MCQ): Mild 50–69, Moderate 35–49, Severe 20–34, Profound <20.
- Most common identifiable / genetic cause = Down syndrome; most common inherited cause = Fragile X; most common preventable cause worldwide = iodine deficiency; most common environmental/teratogenic cause = Fetal Alcohol Syndrome.
- Prevalence ≈ 1–3%, majority mild.
- IQ formula = (mental age / chronological age) × 100; mean 100, SD 15.
- Investigation of adaptive function = Vineland scale; IQ = Stanford-Binet / Wechsler.
- DSM-5 grades severity by adaptive functioning, not IQ — frequently tested "newer concept" question.
- Risperidone for irritability/aggression in ID & autism.
- Onset must be in the developmental period (<18 yrs) — distinguishes from dementia.
- Syndrome-clue MCQs: macro-orchidism (Fragile X), self-mutilation + ↑uric acid (Lesch-Nyhan), hand-wringing in a girl (Rett), hyperphagia/obesity (Prader-Willi), happy-puppet/laughter (Angelman), cat cry (cri-du-chat), musty odour (PKU).
- Chromosomal microarray = first-line genetic test for unexplained ID.
Rapid revision
- ID = deficits in BOTH intellectual + adaptive functioning, onset before 18 years.
- IQ cut-offs: Mild 50–69, Moderate 35–49, Severe 20–34, Profound <20; borderline = 70–84.
- IQ mean = 100, SD = 15; ID starts at 2 SD below mean (IQ <70). IQ = (MA/CA) × 100.
- Prevalence 1–3%; majority (~85%) are MILD; commoner in males.
- Down syndrome = most common identifiable/genetic cause; Fragile X = most common inherited; FAS = most common preventable environmental; iodine deficiency = most common preventable worldwide.
- DSM-5 grades severity by adaptive functioning, not IQ.
- IQ test of choice = Stanford-Binet/Wechsler; adaptive function = Vineland (VABS). India: Bhatia's Battery, Seguin Form Board.
- CMA + Fragile X testing = first-line genetic work-up for unexplained ID.
- No drug cures ID; risperidone/aripiprazole for aggression & self-injury.
- PKU → low-phenylalanine diet; congenital hypothyroidism → levothyroxine = treatable/preventable causes via newborn screening.
- Mild = educable, Moderate = trainable, Severe/Profound = dependent; mild presents late at school entry.
- Under 5 yrs use Global Developmental Delay; beware diagnostic overshadowing of comorbid illness.